American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.
Regulators say the weight-loss drug Wegovy can now be used to treat more than 3 million overweight Australians with heart ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
About a dozen drugmakers are developing new weight-loss treatments aimed at preserving muscle, and industry analysts, ...
Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...
PA Media on MSN3d
Novo Nordisk reprimanded for allegedly failing to disclose paymentsNovo Nordisk, manufacturer of the weight loss jab Wegovy, has been reprimanded for allegedly failing to disclose or ...
Novo Nordisk A/S shares are on track for their worst week this year, after a Super Bowl advertisement touting copycat ...
Swiss drugmaker Roche began a study last year of its experimental drug, RG6237, as a monotherapy in people with high body ...
Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...
Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results